Working in a field where companies are racing to develop newer models and innovative products at a lower price, has made Ken Londoner understand how healthcare demands and needs are shaping and affecting the market growth. He studied at Lafayette College[1] from where he graduated with a degree in economics and finance, and later earned his MBA from NYU’s Stern School of Business, with a dual major in finance and management.

Ken Londoner is founder and executive chairman of BioSig Technologies[2], a medical technology company started in 2009. It is a privately held company working on developing and commercializing a new system that is supposed to help treat more accurately patients suffering from Atrial Fibrillation, or irregular heartbeats. With a keen understanding of the industry issues and a significant executive experience, Ken Londoner has managed to achieve success inside and outside the biomedical industry.[3]

Before engaging in the bio-medical field, Ken Londoner served as Senior Vice President and Investment Officer at one of America’s leading medical firms Inspire MD. During his time there, he was able to become the youngest manager to ever manage the Endicott Management LLC company and the New Cardio Inc, managing transactions, mutual funds, pension funds, and international assets.[4]

External Links Edit

  1. Ken Londoner - Lafayette Alumni
  2. BioSig Technologies Founder Ken Londoner - Equities Interview
  3. BioSig Technologies Interview on MicroCapreSearch
  4. Kenneth Londoner, Co Founder